Español
PDFs by language
Our 24/7 cancer helpline provides support for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Chat live online
Select the Live Chat button at the bottom of the page
At our National Cancer Information Center trained Cancer Information Specialists can answer questions 24 hours a day, every day of the year to empower you with accurate, up-to-date information to help you make educated health decisions. We connect patients, caregivers, and family members with valuable services and resources.
Or ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
For medical questions, we encourage you to review our information with your doctor.
When your prostate was biopsied, the samples taken were studied under the microscope by a specialized doctor with many years of training called a pathologist. The pathologist sends your doctor a report that gives a diagnosis for each sample taken. Information in this report will be used to help manage your care. The questions and answers that follow are meant to help you understand medical language you might find in the pathology report from your prostate biopsy.
The most common type of prostate biopsy is a core needle biopsy. For this procedure, the doctor inserts a thin, hollow needle into the prostate gland. When the needle is pulled out it removes a small cylinder of prostate tissue called a core. This is often repeated several times to sample different areas of the prostate.
Your pathology report will list each core separately by a number (or letter) assigned to it by the pathologist, with each core (biopsy sample) having its own diagnosis. If cancer or some other problem is found, it is often not in every core, so you need to look at the diagnoses for all of the cores to know what is going on with you.
In this condition, there are changes in how the prostate gland cells look under the microscope, but the abnormal cells don't look like they are growing into other parts of the prostate (like cancer cells would). Based on how abnormal the patterns of cells look, they are classified as:
PIN begins to appear in the prostates of some men as early as their 20s. Almost half of all men have PIN by the time they reach 50. High-grade PIN is considered a pre-cancer of the prostate because it may turn into prostate cancer over time. Low-grade PIN in general should not be on a biopsy report, as it has no significance.
No. In most cases high-grade PIN will not turn into cancer over the next several years. Still, the risk of getting cancer later is higher if high-grade PIN is found in more than one biopsy core.
It means there is no cancer in this biopsy sample. In most cases, even a repeat biopsy will not show cancer.
In most cases, the chance of finding cancer is low, so a repeat biopsy done soon after the diagnosis of high-grade PIN is not useful. However, some patients do have a higher risk, such as men with multiple cores showing high-grade PIN. Discuss if and when you have a repeat biopsy with your doctor.
Intraductal carcinoma often represents high-grade prostate cancer that is growing into pre-existing prostate ducts. It is often seen next to high-grade prostate cancer.
In this setting the intraductal carcinoma has no significance and will not change your treatment options or prognosis (outlook).
In this setting, some doctors will recommend treatment, such as surgery or radiation, since intraductal carcinoma is typically associated with high-grade prostate cancer. Other doctors may choose to do a repeat biopsy to try to confirm the high-grade cancer before starting treatment.
The diagnosis of intraductal carcinoma is difficult for pathologists, so you may want to consider asking for a second opinion in this setting.
You should discuss your treatment options with your doctor if your biopsy shows intraductal carcinoma in the absence of usual prostate cancer.
These are special tests that the pathologist sometimes uses to help make the diagnosis of prostate cancer. Not all patients need these tests. Whether or not your report mentions these tests has no effect on the accuracy of your diagnosis.
Inflammation of the prostate is called prostatitis. Most cases of prostatitis reported on biopsy are not from an infection and do not need to be treated. Sometimes, inflammation may increase your PSA level, but it is not linked to prostate cancer.
All of these are terms for things the pathologist might see under the microscope that are benign (not cancer), but sometimes can look like cancer under the microscope.
Atrophy is a term used to describe a shrinkage of prostate tissue (when it is seen under the microscope). When it affects the entire prostate gland it is called diffuse atrophy. This is most often caused by hormones or radiation therapy to the prostate. When atrophy only affects certain areas of the prostate, it is called focal atrophy. Focal atrophy can sometimes look like prostate cancer under the microscope.
Atypical adenomatous hyperplasia (which is sometimes called adenosis) is another benign condition that can sometimes be seen on a prostate biopsy.
The seminal vesicles are glands that lie just behind the prostate. Sometimes part of a seminal vesicle is sampled during a biopsy. This is not a cause for concern.
This series of Frequently Asked Questions (FAQs) was developed by the Association of Directors of Anatomic and Surgical Pathology to help patients and their families better understand what their pathology report means. These FAQs have been endorsed by the College of American Pathologists (CAP) and reviewed by the American Cancer Society.
Learn more about the FAQ Initiative
Last Revised: March 7, 2017
Copyright 2017 Association of Directors of Anatomic and Surgical Pathology, adapted with permission by the American Cancer Society.